
Acanthoside B
CAS No. 7374-79-0
Acanthoside B ( —— )
产品货号. M29085 CAS No. 7374-79-0
Acanthoside B 是一种木酚素,具有抗炎和抗遗忘作用。 Acanthoside B 可用于有关阿尔茨海默病和肺部炎症的研究。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1604 | 有现货 |
![]() ![]() |
10MG | ¥2365 | 有现货 |
![]() ![]() |
25MG | ¥3985 | 有现货 |
![]() ![]() |
50MG | ¥5808 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Acanthoside B
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Acanthoside B 是一种木酚素,具有抗炎和抗遗忘作用。 Acanthoside B 可用于有关阿尔茨海默病和肺部炎症的研究。
-
产品描述Acanthoside B is a lignan with anti-inflammatory and anti-amnesic effects. Acanthoside B can be used for studies about Alzheimer's disease and lung inflammation.(In Vitro):Acanthoside B has inhibitory effects on the allergic inflammation.(In Vivo):Acanthoside B restores the cholinergic activity, decreases the endogenous antioxidant status, suppresses neuroinflammation, and activates the TrkB/CREB/BDNF pathway thereby attenuating Scopolamine inflicted AD-like amnesic traits in mice.
-
体外实验——
-
体内实验Acanthoside B (oral gavage; 10-20 mg/kg; 7 days prior to Scopolamine injection) attenuates Scopolamine inflicted AD-like amnesic traits by restoring the cholinergic activity, decreasing the endogenous antioxidant status, suppressing neuroinflammation, and activating the TrkB/CREB/BDNF pathway in mice. Animal Model:Scopolamine-induced amnesic mouse model Dosage:10 mg/kg; 20 mg/kg Administration:oral gavage; 7 days Result:Exhibited an anti-amnesic effect in mice.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number7374-79-0
-
分子量580.583
-
分子式C28H36O13
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (172.24 mM)
-
SMILESCOc1cc(cc(OC)c1O)[C@H]1OC[C@H]2[C@H]1CO[C@@H]2c1cc(OC)c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(OC)c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册




关联产品
-
PACAP (6-38), human,...
PACAP (6-38), human, ovine, rat TFA is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively.
-
TBOPP
TBOPP 是一种选择性 DOCK1 抑制剂 (IC50 : 8.4 μM),对更广泛的肿瘤类型具有抗肿瘤活性。
-
3,4-Di-O-caffeoylqui...
3,4-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV; it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells.